Publicaciones en colaboración con investigadores/as de Universidad de La Sabana (22)

2024

  1. At-admission prediction of mortality and pulmonary embolism in an international cohort of hospitalised patients with COVID-19 using statistical and machine learning methods

    Scientific Reports, Vol. 14, Núm. 1

  2. Characteristics and outcomes of COVID-19 patients admitted to hospital with and without respiratory symptoms

    Heliyon, Vol. 10, Núm. 10

  3. Optimising Clinical Epidemiology in Disease Outbreaks: Analysis of ISARIC-WHO COVID-19 Case Report Form Utilisation

    Epidemiologia, Vol. 5, Núm. 3, pp. 557-580

2023

  1. A brief history of crystalloids: the origin of the controversy

    Frontiers in Pediatrics

  2. Effectiveness of prolonged versus standard-course of oseltamivir in critically ill patients with severe influenza infection: A multicentre cohort study

    Journal of Medical Virology, Vol. 95, Núm. 8

  3. Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

    Genome Medicine, Vol. 15, Núm. 1

  4. Thrombotic and hemorrhagic complications of COVID-19 in adults hospitalized in high-income countries compared with those in adults hospitalized in low- and middle-income countries in an international registry

    Research and Practice in Thrombosis and Haemostasis, Vol. 7, Núm. 5

2022

  1. ISARIC-COVID-19 dataset: A Prospective, Standardized, Global Dataset of Patients Hospitalized with COVID-19

    Scientific Data, Vol. 9, Núm. 1

  2. Impact of Aspergillus spp. isolation in the first 24 hours of admission in critically ill patients with severe influenza virus pneumonia

    Medicina Intensiva

  3. Impact of Aspergillus spp. isolation in the first 24 hours of admission in critically ill patients with severe influenza virus pneumonia

    Medicina intensiva, Vol. 46, Núm. 8, pp. 426-435

  4. The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 119, Núm. 21

2021

  1. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths

    Science immunology, Vol. 6, Núm. 62

  2. Early oseltamivir treatment improves survival in critically ill patients with influenza pneumonia

    ERJ Open Research, Vol. 7, Núm. 1

2020

  1. Bronchoscopist's perception of the quality of the single-use bronchoscope (Ambu aScope4™) in selected bronchoscopies: a multicenter study in 21 Spanish pulmonology services

    Respiratory Research, Vol. 21, Núm. 1

2019

  1. An international perspective on hospitalized patients with viral community-acquired pneumonia

    European Journal of Internal Medicine, Vol. 60, pp. 54-70

  2. International prevalence and risk factors evaluation for drug-resistant Streptococcus pneumoniae pneumonia

    Journal of Infection, Vol. 79, Núm. 4, pp. 300-311

  3. Prevalence and etiology of community-acquired pneumonia in immunocompromised patients

    Clinical Infectious Diseases, Vol. 68, Núm. 9, pp. 1482-1493

2018

  1. Assessment of ecosystem health disturbance in mangrove-lined Caribbean coastal systems using the oyster Crassostrea rhizophorae as sentinel species

    Science of the Total Environment, Vol. 618, pp. 718-735

  2. Burden and risk factors for Pseudomonas aeruginosa community-acquired pneumonia: A multinational point prevalence study of hospitalised patients

    European Respiratory Journal, Vol. 52, Núm. 2

  3. Corticosteroid treatment in critically ill patients with severe influenza pneumonia: a propensity score matching study

    Intensive Care Medicine, Vol. 44, Núm. 9, pp. 1470-1482